Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease

References

• Michell RH. Evolution of the diverse biological roles of inositols. Biochem Soc Symp. 2007;74:223–246.
   PubMedGoogle Scholar
• Bizzarri M, Carlomagno G. Inositol: history of an effective therapy for Polycystic Ovary Syndrome. Eur Rev Med Pharmacol Sci. 2014;18(13):1896–1903.
   PubMed Web of Science ®Google Scholar
• Tsui MM, York JD. Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes. Adv Enzyme Regul. 2010;50(1):324–337.
   PubMedGoogle Scholar
• Thomas MP, Mills SJ, Potter BV. The “other” inositols and their phosphates: synthesis, biology, and medicine (with recent advances in myo- inositol chemistry). Angew Chem Int Ed Engl. 2016;55(5):1614–1650.
   PubMed Web of Science ®Google Scholar
• Clements RS Jr, Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr. 1980;33(9):1954–1967.
   PubMed Web of Science ®Google Scholar
• Stentz R, Osborne S, Horn N, et al. A bacterial homolog of a eukaryotic inositol phosphate signaling enzyme mediates cross-kingdom dialog in the mammalian gut. Cell Rep. 2014;6(4):646–656.
   PubMed Web of Science ®Google Scholar
• Schlemmer U, Frølich W, Prieto RM, et al. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res. 2009;53(Suppl. 2):S330–75.
   PubMed Web of Science ®Google Scholar
• Goodhart RS. Bioflavonoids. In: Goodhart RS, Shils ME, editors. Modern nutrition in health and disease. Philadelphia: Lea & Febiger; 1973. p. 259–267.
   Google Scholar
• Chu SH, Hegsted DM. Myo-inositol deficiency in gerbils: changes in phospholipid composition of intestinal microsomes. J Nutr. 1980;110(6):1217–1223.
   PubMed Web of Science ®Google Scholar
• De Grazia S, Carlomagno G, Unfer V, et al. Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects. Expert Opin Drug Deliv. 2012;9(9):1033–1039.
   PubMed Web of Science ®Google Scholar
• Harland BF, Morris ER. Phytate: A good or a bad food component? Nutr Res. 1995;15(5):733–754.
   Web of Science ®Google Scholar
• Shamsuddin AM. Demonizing phytate. Nat Biotechnol. 2008;26(5):496–497.
   PubMed Web of Science ®Google Scholar
• Raboy V. Response to demonizing phytate. Nat Biotechnol. 2008;26(5):497–498.
   Google Scholar
• Eisenberg F Jr. D-myo-inositol I-phosphate as product of cyclization of glucose-6-phosphate and substrate for a specific phosphatase in rat testis. J Biol Chem. 1967;242(7):1375–1382.
   PubMed Web of Science ®Google Scholar
• Caspary WF, Crane RK. Active transport of myo-inositol and its relation to the sugar transport system in hamster small intestine. Biochim Biophys Acta. 1970;203:308–316.
   PubMed Web of Science ®Google Scholar
• Nahapetian A, Young VR. Metabolism of 14C-phytate in rats: effect of low and high dietary calcium intakes. J Nutr. 1980;110(7):1458–1472.
   PubMed Web of Science ®Google Scholar
• Carlomagno G, De Grazia S, Unfer V, et al. Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. Expert Opin Drug Deliv. 2012;9(3):267–271.
   PubMed Web of Science ®Google Scholar
• Daughaday WH, Larner J. The renal excretion of inositol in normal and diabetic human beings. J Clin Invest. 1954;33(3):326–332.
   PubMed Web of Science ®Google Scholar
• Holub BJ. 1982 Borden Award lecture. Nutritional, biochemical, and clinical aspects of inositol and phosphatidylinositol metabolism. Can J Physiol Pharmacol. 1984;62(1):1–8.
   PubMed Web of Science ®Google Scholar
• Brusati V, Joźwik M, Joźwik M, et al. Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term. Pediatr Res. 2005 Oct;58(4):700–704.
   PubMed Web of Science ®Google Scholar
• Servo C, Pitkänen E. Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients. Diabetologia. 1975;11(6):575–580.
   PubMed Web of Science ®Google Scholar
• Howlett A, Ohlsson A, Plakkal N. Inositol in preterm infants at risk for or having respiratory distress syndrome. Cochrane Database Syst Rev. 2015;2:CD000366.
   PubMed Web of Science ®Google Scholar
• Schneider S. Inositol transport proteins. FEBS Lett. 2015;589(10):1049–1058.
   PubMed Web of Science ®Google Scholar
• Bourgeois F, Coady MJ, Lapointe JY. Determination of transport stoichiometry for two cation-coupled myo-inositol cotransporters: SMIT2 and HMIT. J Physiol. 2005;563(Pt 2):333–343.
   PubMed Web of Science ®Google Scholar
• Preston AS, Yamauchi A, Kwon HM, et al. Activators of protein kinase A and of protein kinase C inhibit MDCK cell myo-inositol and betaine uptake. J Am Soc Nephrol. 1995;6(6):1559–1564.
   PubMed Web of Science ®Google Scholar
• Prpić V, Blackmore PF, Exton JH. myo-Inositol uptake and metabolism in isolated rat liver cells. J Biol Chem. 1982;257(19):11315–11322.
   PubMed Web of Science ®Google Scholar
• Kollros PE, Goldstein GW, Betz AL. Myo-inositol transport into endothelial cells derived from nervous system microvessels. Brain Res. 1990;511(2):259–264.
   PubMed Web of Science ®Google Scholar
• Greene DA, Lattimer SA. Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect. J Clin Invest. 1982;70(5):1009–1018.
   PubMed Web of Science ®Google Scholar
• Uldry M, Ibberson M, Horisberger JD, et al. Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. Embo J. 2001;20(16):4467–4477.
   PubMed Web of Science ®Google Scholar
• Uldry M, Steiner P, Zurich MG, et al. Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones. Embo J. 2004;23(3):531–540.
   PubMed Web of Science ®Google Scholar
• Di Daniel E, Mok MH, Mead E, et al. Evaluation of expression and function of the H+/myo-inositol transporter HMIT. BMC Cell Biol. 2009;10:54.
   PubMed Web of Science ®Google Scholar
• Dawson RM, Freinkel N. The distribution of free meso-inositol in mammalian tissues, including some observations on the lactating rat. Biochem J. 1961;78(3):606–610.
   PubMed Web of Science ®Google Scholar
• Lewin LM, Beer R. Prostatic secretion as the source of myo-inositol in human seminal fluid. Fertil Steril. 1973;24(9):666–670.
   PubMed Web of Science ®Google Scholar
• Hinton BT, White RW, Setchell BP. Concentrations of myo-inositol in the luminal fluid of the mammalian testis and epididymis. J Reprod Fertil. 1980;58(2):395–399.
   PubMedGoogle Scholar
• Spector R, Lorenzo AV. The origin of myo-inositol in brain, cerebrospinal fluid and choroid plexus. J Neurochem. 1975 Sep;25(3):353–354.
   PubMed Web of Science ®Google Scholar
• The vitamins: fundamental aspects in nutrition and health. 3rd ed. Combs GF Jr, editor. New York: Elsevier Academic Press; 2007. p. 411.
   Google Scholar
• Burton LE, Ray RE, Bradford JR, et al. myo-Inositol metabolism in the neonatal and developing rat fed a myo-inositol-free diet. J Nutr. 1976;106(11):1610–1616.
   PubMed Web of Science ®Google Scholar
• Loewus MW, Loewus FA, Brillinger GU, et al. Stereochemistry of the myo-inositol-1-phosphate synthase reaction. J Biol Chem. 1980;255(24):11710–11712.
   PubMed Web of Science ®Google Scholar
• Murray M, Greenberg ML. Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate. Mol Microbiol. 2000;36(3):651–661.
   PubMed Web of Science ®Google Scholar
• Ju S, Greenberg ML. 1D-myo-inositol 3-phosphate synthase: conservation, regulation, and putative target of mood stabilizers. Clin Neurosci Res. 2004;4(3–4):181–187.
   Web of Science ®Google Scholar
• Hasegawa R, Eisenberg F Jr. Selective hormonal control of myo-inositol biosynthesis in reproductive organs and liver of the male rat. Proc Natl Acad Sci U S A. 1981;78(8):4863–4866.
   PubMed Web of Science ®Google Scholar
• Azab AN, He Q, Ju S, et al. Glycogen synthase kinase-3 is required for optimal de novo synthesis of inositol. Mol Microbiol. 2007;63(4):1248–1258.
   PubMed Web of Science ®Google Scholar
• Whiting PH, Palmano KP, Hawthorne JN. Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochem J. 1979;179(3):549–553.
   PubMed Web of Science ®Google Scholar
• Ye C, Greenberg ML. Inositol synthesis regulates the activation of GSK-3α in neuronal cells. J Neurochem. 2015;133(2):273–283.
   PubMed Web of Science ®Google Scholar
• Spector R. Inositol accumulation by brain slices in vitro. J Neurochem. 1976;27(5):1273–1276.
   PubMed Web of Science ®Google Scholar
• Stokes CE, Gillon KR, Hawthorne JN. Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochim Biophys Acta. 1983;753(1):136–138.
   PubMed Web of Science ®Google Scholar
• Pitkänen E. Changes in serum and urinary myo-inositol levels in chronic glomerulonephritis. Clin Chim Acta. 1976;71(3):461–468.
   PubMed Web of Science ®Google Scholar
• Carlomagno G, Unfer V. Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011;15(8):931–936.
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009;91(5):1750–1754.
   PubMed Web of Science ®Google Scholar
• Barak Y, Levine J, Glasman A, et al. Inositol treatment of Alzheimer’s disease: a double blind, cross-over placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(4):729–735.
   PubMed Web of Science ®Google Scholar
• FDA: U.S. Food and Drug Administration. Select Committee on GRAS Substances (SCOGS) Opinion: Inositol; [ cited 2015 Nov 16]. Available from: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260436.htm.
   Google Scholar
• Irvine RF, Schell MJ. Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol. 2001;2(5):327–338.
   PubMed Web of Science ®Google Scholar
• Pak Y, Huang LC, Lilley KJ, et al. In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J Biol Chem. 1992;267(24):16904–16910.
   PubMed Web of Science ®Google Scholar
• Yancey PH. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J Exp Biol. 2005;208(Pt 15):2819–2830.
   PubMed Web of Science ®Google Scholar
• McLaurin J, Golomb R, Jurewicz A, et al. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem. 2000;275(24):18495–18502.
   PubMed Web of Science ®Google Scholar
• Pak Y, Paule CR, Bao YD, et al. Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc Natl Acad Sci USA. 1993;90(16):7759–7763.
   PubMed Web of Science ®Google Scholar
• Holub BJ. The Mn2+-activated incorporation of inositol into molecular species of phosphatidylinositol in rat liver microsomes. BiochimBiophysActa. 1974;369(1):111–122.
   PubMed Web of Science ®Google Scholar
• Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol. 1999;11(2):219–225.
   PubMed Web of Science ®Google Scholar
• Bulley SJ, Clarke JH, Droubi A, et al. Exploring phosphatidylinositol 5-phosphate 4-kinase function. Adv Biol Regul. 2015;57:193–202.
   PubMedGoogle Scholar
• Rameh LE, Tolias KF, Duckworth BC, et al. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature. 1997;390(6656):192–196.
   PubMed Web of Science ®Google Scholar
• Pettitt TR, Dove SK, Lubben A, et al. Analysis of intact phosphoinositides in biological samples. J Lipid Res. 2006;47(7):1588–1596.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098–1101.
   PubMed Web of Science ®Google Scholar
• Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem. 2001;70:247–279.
   PubMed Web of Science ®Google Scholar
• Taylor V, Wong M, Brandts C, et al. 5ʹ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol. 2000;20(18):6860–6871.
   PubMed Web of Science ®Google Scholar
• Choi Y I, Zhang J, Murga C, et al. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene. 2002;21(34):5289–5300.
   PubMed Web of Science ®Google Scholar
• English PD, Dietz M, Albersheim P. Myoinositol kinase: partial purification and identification of product. Science. 1966;151(3707):198–199.
   PubMed Web of Science ®Google Scholar
• Stephens LR, Kay RR, Irvine RF. A myo-inositol D-3 hydroxykinase activity in Dictyostelium. Biochem J. 1990;272(1):201–210.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986;233(4761):305–312.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Inositol trisphosphate and calcium signaling mechanisms. Biochim Biophys Acta. 2009;1793(6):933–940.
   PubMed Web of Science ®Google Scholar
• Irvine RF. ‘Quanta’ Ca2+ release and the control of Ca2+ entry by inositol phosphates - a possible mechanism. FEBS Lett. 1990;263(1):5–9.
   PubMed Web of Science ®Google Scholar
• Michell RH. The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem. 1997;32:31–47.
   PubMed Web of Science ®Google Scholar
• Irvine RF, Letcher AJ, Heslop JP, et al. The inositol tris/tetrakisphosphate pathway—demonstration of Ins(l,4,5)P3 3-kinase activity in animal tissues. Nature. 1986;320:631–634.
   PubMed Web of Science ®Google Scholar
• Shears SB. The versatility of inositol phosphates as cellular signals. Biochim Biophys Acta. 1998;1436(1–2):49–67.
   PubMed Web of Science ®Google Scholar
• Irvine RF. 20 years of Ins(1,4,5)P3, and 40 years before. Nat Rev Mol Cell Biol. 2003;4(7):586–590.
   PubMed Web of Science ®Google Scholar
• Livermore TM, Azevedo C, Kolozsvari B, et al. Phosphate, inositol and polyphosphates. Biochem Soc Trans. 2016;44(1):253–259.
   PubMed Web of Science ®Google Scholar
• Downes CP, Macphee CH. myo-Inositol metabolites as cellular signals. Eur J Biochem. 1990;193(1):1–18.
   PubMedGoogle Scholar
• Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 1980;255(22):10896–10901.
   PubMed Web of Science ®Google Scholar
• Grases F, Simonet BM, Prieto RM, et al. Variation of InsP4,InsP5 and InsP6 levels in tissues and biological fluids depending on dietary phytate. J Nutr Biochem. 2001;12(10):595–601.
   PubMed Web of Science ®Google Scholar
• Lakin-Thomas PL. Effects of inositol starvation on the levels of inositol phosphates and inositol lipids in Neurospora crassa. Biochem J. 1993;292(Pt 3):805–811.
   PubMed Web of Science ®Google Scholar
• Shears SB. Molecular basis for the integration of inositol phosphate signaling pathways via human ITPK1. Adv Enzyme Regul. 2009;49(1):87–96.
   PubMedGoogle Scholar
• Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95(10):1811–1827.
   PubMed Web of Science ®Google Scholar
• Goel M, Azev VN, d’Alarcao M. The biological activity of structurally defined inositol glycans. Future Med Chem. 2009;1(1):95–118.
   PubMed Web of Science ®Google Scholar
• Illies C, Gromada J, Fiume R, et al. Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science. 2007;318(5854):1299–1302.
   PubMed Web of Science ®Google Scholar
• Sbrissa D, Ikonomov OC, Strakova J, et al. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology. 2004;145(11):4853–4865.
   PubMed Web of Science ®Google Scholar
• Grasberger H, Van Sande J, Hag-Dahood Mahameed A, et al. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab. 2007;92(7):2816–2820.
   PubMed Web of Science ®Google Scholar
• Hakim S, Bertucci MC, Conduit SE, et al. Inositol polyphosphate phosphatases in human disease. Curr Top Microbiol Immunol. 2012;362:247–314.
   PubMed Web of Science ®Google Scholar
• Santamaria A, Giordano D, Corrado F, et al. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric. 2012;15(5):490–495.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Di Benedetto A, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: A randomized controlled trial. Obstet Gynecol. 2015;126(2):310–315.
   PubMed Web of Science ®Google Scholar
• Chau JF, Lee MK, Law JW, et al. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. Faseb J. 2005;19(13):1887–1889.
   PubMed Web of Science ®Google Scholar
• Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev. 2002;60(3):80–87.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Nestler JE, Ostlund RE, et al. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod. 2008;23(6):1439–1446.
   PubMed Web of Science ®Google Scholar
• Heimark D, McAllister J, Larner J. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J. 2014;61(2):111–117.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Bizzarri M, Benvenga S, et al. Results from the international consensus conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol. 2015;195:72–76.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Tsutsumi K, Kanematsu T, et al. Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels. Biol Reprod. 2009;81(4):681–689.
   PubMed Web of Science ®Google Scholar
• Janovick JA, Conn PM. Gonadotropin-releasing hormone (GnRH)-receptor coupling to inositol phosphate and prolactin production in GH3 cells stably transfected with rat GnRH receptor complementary deoxyribonucleic acid. Endocrinology. 1994;135(5):2214–2219.
   PubMed Web of Science ®Google Scholar
• Carlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril. 2011;95(8):2515–2516.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Iuorno MJ, Apridonidze T, et al. Uncoupling between insulin and release of a D-Chiro-Inositol-Containing Inositol phosphoglycan mediator of insulin action in obese women with Polycystic Ovary Syndrome. Metab Syndr Relat Disord. 2010;8(2):127–135.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–1320.
   PubMed Web of Science ®Google Scholar
• Chiu TT, Rogers MS, Law EL, et al. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002;17(6):1591–1596.
   PubMed Web of Science ®Google Scholar
• Goud PT, Goud AP, Van Oostveldt P, et al. Presence and dynamic redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions. Mol Hum Reprod. 1999;5(5):441–451.
   PubMed Web of Science ®Google Scholar
• Stachecki JJ, Armant DR. Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development. Development. 1996;122(8):2485–2496.
   PubMed Web of Science ®Google Scholar
• Kane MT, Norris M, Harrison RA. Uptake and incorporation of inositol by preimplantation mouse embryos. J Reprod Fertil. 1992;96(2):617–625.
   PubMedGoogle Scholar
• Colazingari S, Fiorenza MT, Carlomagno G, et al. Improvement of mouse embryo quality by myo-inositol supplementation of IVF media. J Assist Reprod Genet. 2014;31(4):463–469.
   PubMed Web of Science ®Google Scholar
• Warner SM, Conlon FV, Kane MT. Inositol transport in preimplantation rabbit embryos: effects of embryo stage, sodium, osmolality and metabolic inhibitors. Reproduction. 2003;125(4):479–493. Erratum in: Reproduction 2005;129(1):128.
   PubMed Web of Science ®Google Scholar
• Colone M, Marelli G, Unfer V, et al. Inositol activity in oligoasthenoteratospermia–an in vitro study. Eur Rev Med Pharmacol Sci. 2010;14(10):891–896.
   PubMed Web of Science ®Google Scholar
• Condorelli RA, La Vignera S, Di Bari F, et al. Effects of myo-inositolon sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011;15(2):129–134.
   PubMed Web of Science ®Google Scholar
• Condorelli RA, La Vignera S, Bellanca S, et al. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79(6):1290–1295.
   PubMed Web of Science ®Google Scholar
• Huang C, Liang NC. Increase in cytoskeletal actin induced by inositol 1,4-bisphosphate in saponin-permeated pig platelets. Cell Biol Int. 1994;18(8):797–804.
   PubMed Web of Science ®Google Scholar
• Dai Z, Chung SK, Miao D, et al. Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation. J Bone Miner Res. 2011;26(3):582–590.
   PubMed Web of Science ®Google Scholar
• Chau JF, Lee MK, Law JW, et al. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. Faseb J. 2005;19(13):1887–1889.
   PubMed Web of Science ®Google Scholar
• Godfrey DA, Hallcher LM, Laird MH, et al. Distribution of myo-inositol in the cat cochlear nucleus. J Neurochem. 1982;38(4):939–947.
   PubMed Web of Science ®Google Scholar
• Greene ND, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med. 1997;3(1):60–66.
   PubMed Web of Science ®Google Scholar
• Reece EA, Khandelwal M, Wu YK, et al. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol. 1997;176(3):536–539.
   PubMed Web of Science ®Google Scholar
• Hallman M, Saugstad OD, Porreco RP, et al. Role of myo-inositol in regulation of surfactant phospholipids in the newborn. Early Hum Dev. 1985;10(3–4):245–254.
   PubMed Web of Science ®Google Scholar
• Anceschi MM, Petrelli A, Zaccardo G, et al. Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses. Pediatr Res. 1988;24(5):617–621.
   PubMed Web of Science ®Google Scholar
• Hallman M, Pohjavuori M, Bry K. Inositol supplementation in respiratory distress syndrome. Lung. 1990;168(Suppl):877–882.
   PubMed Web of Science ®Google Scholar
• Hallman M, Epstein BL. Role of myo-inositol in the synthesis of phosphatidylglycerol and phosphatidylinositol in the lung. Bioch Biophys Res Comm. 1980;92(4):1151–1159.
   PubMed Web of Science ®Google Scholar
• Dasilva KA, Shaw JE, McLaurin J. Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention. Exp Neurol. 2010;223(2):311–321.
   PubMed Web of Science ®Google Scholar
• Teranishi Y, Inoue M, Yamamoto NG, et al. Proton myo-inositol cotransporter is a novel γ-secretase associated protein that regulates Aβ production without affecting Notch cleavage. Febs J. 2015;282(17):3438–3451.
   PubMed Web of Science ®Google Scholar
• Shankar GM, Bloodgood BL, Townsend M, et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007;27(11):2866–2875.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5(6):443–450.
   PubMed Web of Science ®Google Scholar
• Schäfer MK, Pfeiffer A, Jaeckel M, et al. Regulators of mitochondrial Ca(2+) homeostasis in cerebral ischemia. Cell Tissue Res. 2014;357(2):395–405.
   PubMed Web of Science ®Google Scholar
• Gustafson AM, Soldi R, Anderlind C, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med. 2010;2(26):26ra25.
   PubMed Web of Science ®Google Scholar
• Hedgepeth CM, Conrad LJ, Zhang J, et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol. 1997;185(1):82–91.
   PubMed Web of Science ®Google Scholar
• Shamsuddin AKM, Vucenik I. IP6 & inositol in cancer prevention and therapy. Curr Cancer Ther Rev. 2005;1(3):259–269.
   Google Scholar
• Wattenberg LW, Estensen RD. Chemopreventive effects of myo-inositol and dexamethasone on benzo(a)pyrene and 4-(methyl-nitrosamine)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 1996;56(22):5132–5135.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Upadhyaya P, Wang M, et al. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis. 2002;23(9):1455–1461.
   PubMed Web of Science ®Google Scholar
• Lam S, McWilliams A, LeRiche J, et al. A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1526–1531.
   PubMed Web of Science ®Google Scholar
• Shafie NH, Mohd Esa N, Ithnin H, et al. Preventive Inositol Hexaphosphate extracted from rice bran inhibits colorectal cancer through involvement of Wnt/β-catenin and COX-2 pathways. Biomed Res Int. 2013;2013:681027.
   PubMed Web of Science ®Google Scholar
• Windhorst S, Lin H, Blechner C, et al. Tumour cells can employ extracellular Ins(1,2,3,4,5,6)P6 and multiple inositol-polyphosphate phosphatase 1 (MINPP1) dephosphorylation to improve their proliferation. Biochem J. 2013;450(1):115–125.
   PubMed Web of Science ®Google Scholar
• Gu M, Raina K, Agarwal C, et al. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells. Mol Carcinog. 2010;49(1):1–12.
   PubMed Web of Science ®Google Scholar
• Djiogue S, Nwabo Kamdje AH, Vecchio L, et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer. 2013;20(1):R1–R17.
   PubMed Web of Science ®Google Scholar
• Izzotti A, Balansky R, D’Agostini F, et al. Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents. Carcinogenesis. 2013;34(10):2322–2329.
   PubMed Web of Science ®Google Scholar
• Kassie F, Kalscheuer S, Matise I, et al. Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice. Carcinogenesis. 2010;31(2):239–245.
   PubMed Web of Science ®Google Scholar
• Kassie F, Melkamu T, Endalew A, et al. Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination. Carcinogenesis. 2010;31(9):1634–1641.
   PubMed Web of Science ®Google Scholar
• Han W, Gills JJ, Memmott RM, et al. The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev Res (Phila). 2009;2(4):370–376.
   PubMed Web of Science ®Google Scholar
• Gustafson AM I, Soldi R, Anderlind C, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med. 2010;2(26):26ra25.
   PubMed Web of Science ®Google Scholar
• NIH Clinical Trials. Available from: https://clinicaltrials.gov/ct2/show/results/NCT00783705?sect=X01256#all
   Google Scholar
• Dinicola S, Fabrizi G, Masiello MG, et al. Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement. Exp Cell Res. 2016;345(1):37–50.
   PubMed Web of Science ®Google Scholar
• Koguchi T, Tanikawa C, Mori J, et al. Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway. Int J Oncol. 2016;48(6):2415–2424.
   PubMed Web of Science ®Google Scholar
• Guarner V, Tordet C, Bourbon JR. Effects of maternal protein-calorie malnutrition on the phospholipid composition of surfactant isolated from the fetal and neonatal rat lungs. Compensation by inositol and lipid supplementation. Pediatr Res. 1992;31(6):629–635.
   PubMed Web of Science ®Google Scholar
• Hallman M, Spragg R, Harrell JH, et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982;70(3):673–683.
   PubMed Web of Science ®Google Scholar
• Gilmore AP, Burridge K. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature. 1996;381(6582):531–535.
   PubMed Web of Science ®Google Scholar
• Pereira GR, Baker L, Egler J, et al. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. Am J Clin Nutr. 1990;51(4):589–593.
   PubMed Web of Science ®Google Scholar
• Dinicola S, Chiu TT, Unfer V, et al. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol. 2014;54(10):1079–1092.
   PubMed Web of Science ®Google Scholar
• Bevilacqua A, Bizzarri M. Physiological role and clinical utility of inositols in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2016. pii: S1521-6934(16)30006-2. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kamenov Z, Kolarov G, Gateva A, et al. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015;31(2):131–135.
   PubMed Web of Science ®Google Scholar
• Hautanen A. Synthesis and regulation of sex hormone-binding globulin in obesity. Int J Obes Relat Metab Disord. 2000;24(Suppl 2):S64–70.
   PubMedGoogle Scholar
• Bizzarri M, Cucina A, Dinicola S, et al. Does myo-inositol effect on PCOS follicles involve cytoskeleton regulation? Med Hypotheses. 2016;91:1–5.
   PubMed Web of Science ®Google Scholar
• Rondanelli M, Perna S, Faliva M, et al. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena. Arch Gynecol Obstet. 2014;290(6):1079–1092.
   PubMed Web of Science ®Google Scholar
• Sun TH, Heimark DB, Nguygen T, et al. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002;293(3):1092–1098.
   PubMed Web of Science ®Google Scholar
• Isabella R, Raffone E. Does ovary need D-chiro-inositol? J Ovarian Res. 2012;5(1):14.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Unfer V. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol. 2015;31(7):501–505.
   PubMed Web of Science ®Google Scholar
• Cryns K, Shamir A, Van Acker N, et al. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology. 2008;33(3):674–684.
   PubMed Web of Science ®Google Scholar
• Lowther KM, Weitzman VN, Maier D, et al. Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes. Biol Reprod. 2009;81(1):147–154.
   PubMed Web of Science ®Google Scholar
• Chiu TT, Rogers MS, Briton-Jones C, et al. Effects of myo- inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod. 2003;18(2):408–416.
   PubMed Web of Science ®Google Scholar
• Quirk JG Jr, Bleasdale JE. Myo-Inositol homeostasis in the human fetus. Obstet Gynecol. 1983;62(1):41–44.
   PubMed Web of Science ®Google Scholar
• Goldman AS, Goto MP. Biochemical basis of the diabetic embryopathy. Isr J Med Sci. 1991;27(8–9):469–477.
   PubMedGoogle Scholar
• Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002;82(4):736–754.
   PubMed Web of Science ®Google Scholar
• Best MD, Zhang H, Prestwich GD. Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity. Nat Prod Rep. 2010;27(10):1403–1430.
   PubMed Web of Science ®Google Scholar
• Sasakawa N, Sharif M, Hanley MR. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem Pharmacol. 1995;50(2):137–146.
   PubMed Web of Science ®Google Scholar
• Voevodskaya O, Sundgren PC, Strandberg O, et al. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease. Neurology. 2016;86(19):1754–1761.
   PubMed Web of Science ®Google Scholar
• Ito E, Oka K, Etcheberrigaray R, et al. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91(2):534–538.
   PubMed Web of Science ®Google Scholar
• LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci. 2002;3(11):862–872.
   PubMed Web of Science ®Google Scholar
• Leissring MA, Murphy MP, Mead TR, et al. A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP. Proc Natl Acad Sci U S A. 2002;99(7):4697–4702.
   PubMed Web of Science ®Google Scholar
• Cheung KH, Shineman D, Müller M, et al. Mechanism of Ca2+ disruption in Alzheimer’s disease by presenilin regulation of InsP3 receptor channel gating. Neuron. 2008;58(6):871–883.
   PubMed Web of Science ®Google Scholar
• Jesch SA, Zhao X, Wells MT, et al. Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. J Biol Chem. 2005;280(10):9106–9118.
   PubMed Web of Science ®Google Scholar
• Puniya BL, Allen L, Hochfelder C, et al. Systems perturbation analysis of a large-scale signal transduction model reveals potentially influential candidates for cancer therapeutics. Front Bioeng Biotechnol. 2016;4:10. doi:10.3389/fbioe.2016.00010.
   PubMed Web of Science ®Google Scholar
• Shi Y, Azab AN, Thompson MN, et al. Inositol phosphates and phosphoinositides in health and disease. Subcell Biochem. 2006;39:265–292.
   PubMedGoogle Scholar
• Macbeth MR, Schubert HL, Vandemark AP, et al. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science. 2005;309(5740):1534–1539.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Hara H. Phytatehydrolysate induces circumferential F-actin ring formation at cell–cell contacts by a Rho-associated kinase dependent mechanism in colorectal cancer HT-29 cells. Mol Nutr Food Res. 2010;54(12):1807–1818.
   PubMed Web of Science ®Google Scholar
• Seeds AM, York JD. Inositol polyphosphate kinases: regulators of nuclear function. Biochem Soc Symp. 2007;74(74):183–197.
   PubMedGoogle Scholar
• Odom AR, Stahlberg A, Wente SR, et al. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science. 2000;287(5460):2026–2029.
   PubMed Web of Science ®Google Scholar
• Shen X, Xiao H, Ranallo R, et al. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science. 2003;299(5603):112–114.
   PubMed Web of Science ®Google Scholar
• Meinke P, Makarov AA, LêThành P, et al. Nucleoskeleton dynamics and functions in health and disease. Cell Health Cytoskelet. 2015;7:55–69.
   Web of Science ®Google Scholar